Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 28
Gene Symbol: ABO
ABO
0.010 Biomarker disease BEFREE ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To 'B' or Not to 'B'. 31760829 2019
Entrez Id: 30014
Gene Symbol: SPANXA1
SPANXA1
0.010 Biomarker disease BEFREE Novel associations between SPANXA1 and thyroid cancer were described in the current study. 31289536 2019
Entrez Id: 2990
Gene Symbol: GUSB
GUSB
0.010 AlteredExpression disease BEFREE The three algorithms were in agreement in identifying GUSB and HPRT1 as the most stably expressed genes in all thyroid tumors investigated. 31645594 2019
Entrez Id: 407023
Gene Symbol: MIR299
MIR299
0.010 AlteredExpression disease BEFREE MiR-299-3p expression level in both TC tissues and cell lines was determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). 30657565 2019
Entrez Id: 84793
Gene Symbol: FOXD2-AS1
FOXD2-AS1
0.010 AlteredExpression disease BEFREE FOXD2-AS1 expression was evaluated by analyzing thyroid cancer RNA sequencing dataset from The Cancer Genome Atlas (TCGA). 31024447 2019
Entrez Id: 3688
Gene Symbol: ITGB1
ITGB1
0.010 Biomarker disease BEFREE We found that the protein abundance of OPN and its receptor, integrin β1, was highly increased and, concurrently, the downstream effectors AKT and NF-κB were significantly elevated to drive thyroid tumor progression of <i>Thrb<sup>PV/PV</sup>Pten<sup>+/-</sup></i> mice. 31392080 2019
Entrez Id: 406948
Gene Symbol: MIR15A
MIR15A
0.010 Biomarker disease BEFREE Long non-coding RNA UCA1 exerts growth modulation by miR-15a in human thyroid cancer TPC-1 cells. 31062608 2019
Entrez Id: 26155
Gene Symbol: NOC2L
NOC2L
0.010 Biomarker disease BEFREE Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy. 31279897 2019
Entrez Id: 2596
Gene Symbol: GAP43
GAP43
0.010 Biomarker disease BEFREE Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition. 31568662 2019
Entrez Id: 9122
Gene Symbol: SLC16A4
SLC16A4
0.010 Biomarker disease BEFREE A total of 15 targeted studies and 16 untargeted studies revealed several potential metabolite signatures of TC such as glucose, fructose, galactose, mannose, 2-keto-d-gluconic acid and rhamnose, malonic acid and inosine, cholesterol and arachidonic acid, glycosylation (immunoglobulin G [IgG] Fc-glycosylation), outer mitochondrial membrane 20 (TOMM20), monocarboxylate transporter 4 (MCT4), choline, choline derivatives, myo-/scyllo-inositol, lactate, fatty acids, several amino acids, cell membrane phospholipids, estrogen metabolites such as 16 alpha-OH E1/2-OH E1 and catechol estrogens (2-OH E1), and purine and pyrimidine metabolites, which were suggested as the TC oncometabolite. 30881111 2019
Entrez Id: 8322
Gene Symbol: FZD4
FZD4
0.010 GeneticVariation disease BEFREE GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer. 31289610 2019
Entrez Id: 846
Gene Symbol: CASR
CASR
0.010 Biomarker disease BEFREE Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. 31337787 2019
Entrez Id: 6687
Gene Symbol: SPG7
SPG7
0.010 Biomarker disease BEFREE Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. 31337787 2019
Entrez Id: 10370
Gene Symbol: CITED2
CITED2
0.010 Biomarker disease BEFREE GINS2 plays an important role in cell proliferation and apoptosis of thyroid cancer by regulating the expressions of CITED2 and LOXL2, which may be a potential biomarker for diagnosis or prognosis and a drug target for therapy. 30177819 2019
Entrez Id: 1999
Gene Symbol: ELF3
ELF3
0.010 AlteredExpression disease BEFREE The MAPK signaling pathway inhibitor PLX4032 was demonstrated to strongly attenuate ELF3 protein levels in BRAF‑mutant thyroid cancer cell lines. 30365150 2019
Entrez Id: 353500
Gene Symbol: BMP8A
BMP8A
0.010 AlteredExpression disease BEFREE We identified aberrant high-expression of BMP8A in thyroid cancer, which associated with unfavorable prognosis and tumor progression. 31656161 2019
Entrez Id: 51659
Gene Symbol: GINS2
GINS2
0.010 Biomarker disease BEFREE GINS2 plays an important role in cell proliferation and apoptosis of thyroid cancer by regulating the expressions of CITED2 and LOXL2, which may be a potential biomarker for diagnosis or prognosis and a drug target for therapy. 30177819 2019
Entrez Id: 1646
Gene Symbol: AKR1C2
AKR1C2
0.010 AlteredExpression disease BEFREE We down-/up-regulated the expression of AKR1C2 and explored its specific role in thyroid cancer cell lines by utilizing the si-RNA and plasmid. 31293659 2019
Entrez Id: 9804
Gene Symbol: TOMM20
TOMM20
0.010 Biomarker disease BEFREE A total of 15 targeted studies and 16 untargeted studies revealed several potential metabolite signatures of TC such as glucose, fructose, galactose, mannose, 2-keto-d-gluconic acid and rhamnose, malonic acid and inosine, cholesterol and arachidonic acid, glycosylation (immunoglobulin G [IgG] Fc-glycosylation), outer mitochondrial membrane 20 (TOMM20), monocarboxylate transporter 4 (MCT4), choline, choline derivatives, myo-/scyllo-inositol, lactate, fatty acids, several amino acids, cell membrane phospholipids, estrogen metabolites such as 16 alpha-OH E1/2-OH E1 and catechol estrogens (2-OH E1), and purine and pyrimidine metabolites, which were suggested as the TC oncometabolite. 30881111 2019
Entrez Id: 27075
Gene Symbol: TSPAN13
TSPAN13
0.010 AlteredExpression disease BEFREE Here we investigated the role of miR-369-3p in papillary thyroid cancer (PTC) and its association with TSPAN13. miR-369-3p and the TSPAN13 gene expression profiles of 513 thyroid cancer and 59 normal thyroid tissues were downloaded from the Cancer Genome Atlas database. 30114378 2019
Entrez Id: 57565
Gene Symbol: KLHL14
KLHL14
0.010 Biomarker disease BEFREE <i>MIR182-5p</i> and <i>MIR20a-5p</i> were upregulated in human thyroid cancer and thyroid cancer experimental models and their effects on <i>Pax8</i> and <i>Bcl2</i> were rescued by <i>Klhl14-AS</i> overexpression, confirming <i>Klhl14-AS</i> as a ceRNA for both <i>Pax8</i> and <i>Bcl2</i>. 31558562 2019
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.010 AlteredExpression disease BEFREE Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway. 31180559 2019
Entrez Id: 912
Gene Symbol: CD1D
CD1D
0.010 AlteredExpression disease BEFREE In this study, expression of immunoregulative receptor CD1d and lymphocyte infiltration in different thyroid tumors as well as in healthy tissue were analyzed in order to find new targets for an immunotherapeutic approach. 31560833 2019
Entrez Id: 159989
Gene Symbol: DEUP1
DEUP1
0.010 AlteredExpression disease BEFREE In the present study, a thyroid cancer cell line with stable expression of CCDC67 and luciferase reporter genes was generated and identified. 31611958 2019
Entrez Id: 117196
Gene Symbol: MRGPRX4
MRGPRX4
0.010 GeneticVariation disease BEFREE GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer. 31289610 2019